Source: Virtual Congress 2020 – Host-microbe interactions and their influence on lung disease onset and severity
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
E. Eyraud (Pessac, France), E. Maurat (Pessac, France), P. Vallois (Vandoeuvre-lès-Nancy, France), C. Contin-Bordes (Bordeaux, France), P. Girodet (Pessac, France), M. Thumerel (Pessac, France), P. Berger (Pessac, France), I. Dupin (Pessac, France). A high probability of short-range interactions between fibrocytes and CD8+ T cells potentiates the inflammatory response in chronic obstructive pulmonary disease (COPD) lungs. 1071

Member's Comments

No comment yet.

Related content which might interest you: A high probability of short-range interactions between fibrocytes and CD8 T cells in chronic obstructive pulmonary disease (COPD) lungs Source: International Congress 2019 – Novel mechanisms elucidated by translational studies of COPD Year: 2019 Lymphocyte population and apoptosis in the lungs of smokers and their relation to emphysema Source: Eur Respir J 2001; 17: 946-953 Year: 2001 Pulmonary dendritic cells from chronic obstructive pulmonary disease patients suppress lung immune responses through induction of regulatory T cells Source: Annual Congress 2011 - T-cell subsets Year: 2011 Lung dendritic cells from chronic obstructive pulmonary disease patients induce type 1 T regulatory cells Source: Annual Congress 2012 - Immunologic mechanisms in COPD and asthma Year: 2012 High percentage of CD8+ effector T lymphocytes in patients with chronic obstructive pulmonary disease Source: Eur Respir J 2002; 20: Suppl. 38, 591s Year: 2002 Decreased TCR γδ T lymphocytes in patients with chronic obstructive pulmonary disease Source: Eur Respir J 2003; 22: Suppl. 45, 85s Year: 2003 Phenotype of T cells in lung tissue from smokers with or without chronic obstructive pulmonary disease (COPD) Source: Eur Respir J 2005; 26: Suppl. 49, 53s Year: 2005 Increased CD4+ T-cell infiltration in bronchial epithelium of patients with chronic obstructive pulmonary disease Source: Annual Congress 2007 - Epithelial networks in the airways Year: 2007 STAT4 activation in smokers and patients with chronic obstructive pulmonary disease Source: Eur Respir J 2004; 24: 78-85 Year: 2004 Decreased pulmonary immunoregulatory/suppressor (CD4+CD25+) T-lymphocytes in chronic obstructive pulmonary disease Source: Eur Respir J 2003; 22: Suppl. 45, 85s Year: 2003 High ICAM-1 gene expression in pulmonary fibroblasts of COPD patients: a reflection of an enhanced immunological function Source: Eur Respir J 2006; 28: 113-122 Year: 2006 Decreased FOXP3 expression in small airways of smokers with COPD Source: Eur Respir J 2009; 33: 61-67 Year: 2009 Expression profiling of Th17 associated molecules in bronchoalveolar cells from patients with chronic obstructive pulmonary disease (COPD) Source: Annual Congress 2011 - COPD: clinical studies and animal cell models Year: 2011 T regulatory cells in exacerbation control of chronic obstructive pulmonary disease of mild and moderate stage Source: Annual Congress 2012 - Asthma and COPD: understanding through mechanisms Year: 2012 Levels of CD4CD25 T regulatory cells in bronchial mucosa and peripheral blood of chronic obstructive pulmonary disease indicate involvement of autoimmunity mechanisms Source: International Congress 2019 – Immunopathological mechanisms of lung disease Year: 2019 Low circulating CD34+ cells in chronic obstructive pulmonary disease (COPD) Source: Eur Respir J 2005; 26: Suppl. 49, 362s Year: 2005 T regulatory cells within inflammatory foci of COPD lungs Source: Annual Congress 2008 - Invasive and noninvasive measurements of lung inflammation Year: 2008 The role of regulator and effector T lymphocytes in chronic obstructive pulmonary disease and lung cancer Source: Annual Congress 2010 - Pathology of lung cancer Year: 2010 Lymphoid follicles in (very) severe COPD: beneficial or harmful? Source: Eur Respir J 2009; 34: 219-230 Year: 2009 Evidence of mast-cell activation in a subset of patients with eosinophilic chronic obstructive pulmonary disease Source: Eur Respir J 2002; 20: 325-331 Year: 2002